Predictors of spontaneous transient seizure remission in patients of medically refractory epilepsy due to mesial temporal sclerosis (MTS)

被引:1
作者
Dhiman, Vikas [1 ,2 ]
Sinha, Sanjib [2 ]
Arimappamagan, Arivazhagan [3 ]
Mahadevan, Anita [4 ]
Bharath, Rose Dawn [5 ]
Saini, Jitender [5 ]
Rajeswaran, Jamuna [6 ]
Rao, Malta Bhaskar [3 ]
Shankar, Susrala K. [4 ]
Satishchandra, Parathasarthy [2 ]
机构
[1] Natl Inst Mental Hlth & Neurosci, Dept Clin Neurosci, Bangalore 560029, Karnataka, India
[2] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bangalore 560029, Karnataka, India
[3] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India
[4] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore 560029, Karnataka, India
[5] Natl Inst Mental Hlth & Neurosci, Neuroimaging & Intervent Radiol, Bangalore 560029, Karnataka, India
[6] Natl Inst Mental Hlth & Neurosci, Dept Neuropsychol, Bangalore 560029, Karnataka, India
关键词
Drug resistant epilepsy; Mesial temporal sclerosis; Seizure remission; TLE; HIPPOCAMPAL SCLEROSIS; LOBE EPILEPSY; PROGNOSTIC-FACTOR; ILAE COMMISSION; TASK-FORCE; TRIAL;
D O I
10.1016/j.eplepsyres.2014.11.018
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: To analyze the predictors of spontaneous transient seizure remission for >= 1 year in patients with drug-resistant epilepsy (DRE) due to mesial temporal sclerosis (MTS). Methods: This analysis included 38 patients with DRE (M:F =20:18, age: 31.7 +/- 10.9 years) diagnosed with unilateral MTS (right:left = 16:22). Group I ('remission' group) comprised of patients with seizure remission (M:F =10:8, age: 32.8 +/- 12.3 years, mean seizure free period: 2.2 +/- 1.1 years; median: 2.1 years). Group II ('non-remission' group) comprised of age and gender matched 20 patients (M:F = 10:10, age: 30.7 +/- 9.7 years) with unilateral MTS who never had seizure remission and subsequently underwent epilepsy surgery. Groups I and II were compared to find the predictors associated with transient seizure remission. Results: The age at onset of seizures in group I was 13.2 +/- 11.8 years and in group II was 12.0 +/- 7.6 years. The duration of seizure was: group I - 19.7 +/- 12.5 years and group II - 19.3 +/- 7.7 years. Past history of seizure remissions (p < 0.001), frequent periods of remissions (p <0.001), first remission within a year of onset of seizures (p= 0.04) and normal EEG (p = 0.04) were the important clinical predictors associated with seizure remission in this cohort. Fifteen patients in group I (83.3%) experienced remission following either change in AED (p <= 0.001) or increase in AED dosages (p <0.001). There was no difference between the two groups regarding the type of semiology (partial vs. secondarily generalized) (p = 0.50), family history of seizures (p = 1.0), side of the lesion (p = 0.34), history of febrile seizures (p = 1.0) and the number of AEDs used (p = 0.53). Conclusion: The present study unfolds, some of the clinically relevant predictors associated with transient seizure remission in patients with DRE and MTS. Future molecular and network studies are required to understand its mechanism. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:55 / 61
页数:7
相关论文
共 25 条
  • [21] Is the underlying cause of epilepsy a major prognostic factor for recurrence?
    Semah, F
    Picot, MC
    Adam, C
    Broglin, D
    Arzimanoglou, A
    Bazin, B
    Cavalcanti, D
    Baulac, M
    [J]. NEUROLOGY, 1998, 51 (05) : 1256 - 1262
  • [22] Prognosis of chronic and newly diagnosed epilepsy: revisiting temporal aspects
    Shorvon, Simon
    Luciano, Anna Lisa
    [J]. CURRENT OPINION IN NEUROLOGY, 2007, 20 (02) : 208 - 212
  • [23] Transient seizure remission in intractable localization-related epilepsy
    Takenaka, J
    Aso, K
    Watanabe, K
    Okumura, A
    Negoro, T
    [J]. PEDIATRIC NEUROLOGY, 2000, 23 (04) : 328 - 331
  • [24] Prognosis of patients with mesial temporal lobe epilepsy due to hippocampal sclerosis
    Varoglu, Asuman Orhan
    Saygi, Serap
    Acemoglu, Hamit
    Ciger, Abdurrahman
    [J]. EPILEPSY RESEARCH, 2009, 85 (2-3) : 206 - 211
  • [25] A randomized, controlled trial of surgery for temporal-lobe epilepsy
    Wiebe, S
    Blume, WT
    Girvin, JP
    Eliasziw, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (05) : 311 - 318